Author:
Liu Jieke,Li Dongyan,Ma Huijie,Li Yong,Wei Xing,Dai Wei,Shi Qiuling,Li Qiang,Zhou Peng,Wang Xiang,Qing Haomiao
Funder
National Natural Science Foundation of China
Sichuan Science and Technology Program
Fundamental Research Funds for the Central Universities
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Center. 2022;2:1–9.
2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.
3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer; Version 7.2024. National Comprehensive Cancer Network. 2024. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 2 July 2024.
4. Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399:1607–17.
5. Suzuki K, Watanabe SI, Wakabayashi M, et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg. 2022;163:289-301.e2.